Dissection of the Active Ingredients and Potential Mechanism of Han-Shi-Yu-Fei-Decoction in Treating COVID-19 Based on In Vivo Substances Profiling and Clinical Symptom-Guided Network Pharmacology
Open Access
- 7 October 2022
- journal article
- research article
- Published by American Chemical Society (ACS) in ACS Omega
- Vol. 7 (41) , 36598-36610
Abstract
This work was aimed to elucidate the mechanism of action of Han-Shi-Yu-Fei-decoction (HSYFD) for treating patients with mild coronavi-rus disease 2019 (COVID-19) based on clinical symptom-guided network pharmacology. Experimentally, an ultra-high performance liquid chromatog-raphy technique coupled with quadrupole time-of-flight mass spectrometry method was used to profile the chemical components and the absorbed prototype constituents in rat serum after its oral administration, and 11 out of 108 compounds were identified. Calculatingly, the disease targets of Han-Shi-Yu-Fei symptoms of COVID-19 were constructed through the TCMIP V2.0 database. The subsequent network pharmacology and molecular docking analysis explored the molecular mechanism of the absorbed prototype constituents in the treatment of COVID-19. A total of 42 HSYFD targets oriented by COVID-19 clinical symptom were obtained, with EGFR, TP53, TNF, JAK2, NR3C1, TH, COMT, and DRD2 as the core targets. Enriched pathway analysis yielded multiple COVID-19-related signaling pathways, such as the PI3K/AKT signaling pathway and JAK-STAT pathway. Molecular docking showed that the key compounds, such as 6-gingerol, 10-gingerol, and scopoletin, had high binding activity to the core targets like COMT, JAK2, and NR3C1. Our work also verified the feasibility of clinical symptom-guided network pharmacology analysis of chemical compounds, and provided a possible agreement between the points of views of traditional Chinese medicine and western medicine on the disease.Keywords
Funding Information
- National Natural Science Foundation of China (81830109)
- Shanghai Changzheng Hospital (2020YLCYJ -Y25)
- Jin-Zi-Ta Talent projects (0806, 1016)
This publication has 51 references indexed in Scilit:
- Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, ChinaJAMA Internal Medicine, 2020
- Structural basis for inhibition of the RNA-dependent RNA polymerase from SARS-CoV-2 by remdesivirScience, 2020
- TH17 responses in cytokine storm of COVID-19: An emerging target of JAK2 inhibitor FedratinibJournal of Microbiology, Immunology and Infection, 2020
- Prediction of triptolide targets in rheumatoid arthritis using network pharmacology and molecular dockingInternational Immunopharmacology, 2020
- Establishing a rapid classification and identification method for the major triterpenoids of Alisma orientalePhytochemical Analysis, 2019
- Influence of pharmacological and epigenetic factors to suppress neurotrophic factors and enhance neural plasticity in stress and mood disordersCognitive Neurodynamics, 2019
- Common gut microbial metabolites of dietary flavonoids exert potent protective activities in β-cells and skeletal muscle cellsThe Journal of Nutritional Biochemistry, 2018
- Gingerols and shogaols: Important nutraceutical principles from gingerPhytochemistry, 2015
- Liquid chromatography quadrupole time-of-flight mass spectrometry characterization of metabolites guided by the METLIN databaseNature Protocols, 2013
- Rapid Screening for 67 Drugs and Metabolites in Serum or Plasma by Accurate-Mass LC-TOF-MSJournal of Analytical Toxicology, 2012